https://my.clevelandclinic.org/health/diagnostics/24204-breast-biopsy-overview

If the core transformation of breast biopsy procedures over the past two decades was "visualization", then the theme of the next decade will be "intelligence". Artificial intelligence and robotic technology are quietly infiltrating this seemingly traditional field and are expected to completely revolutionize the way we carry out these procedures.

AI Empowering Program Planning: From "Human Eye Recognition" to "Algorithm Decision-Making"

In traditional procedures, doctors need to manually delineate the boundaries of the lesion and plan the needle insertion path based on their experience from ultrasound or mammography images. However, the AI-assisted system can automatically segment the lesion contour within seconds using a deep learning model and calculate the optimal puncture angle and depth while avoiding blood vessels, chest wall, and skin. For instance, a recent study shows that the average deviation of the AI-planned needle path from the center of the lesion is only 1.2 millimeters, which is lower than 1.8 millimeters by experienced doctors. This means the procedure will be safer and more efficient, especially for inexperienced young doctors. The AI is like an "invisible mentor".

The Robot Executes the Program: Breaking Through Human Physiological Limits

The stability and precision of the robotic arm far exceed those of human hands. The new breast puncture robot system can control the target locking accuracy within 0.5 millimeters and can compensate for the tiny displacements caused by breathing movements. When performing complex procedures such as vacuum-assisted rotary cutting that require multiple repetitive operations, the robot can automatically complete the entire process of rotary cutting, needle withdrawal, and needle reinsertion according to the preset program, freeing the doctor's hands and avoiding errors caused by human fatigue. Some prototypes have even achieved remote control, enabling patients in remote areas to enjoy the program plans of top experts.

Real-Time Feedback During Surgery: The "Referee" for Program Quality

Another groundbreaking advancement is real-time tissue analysis. In traditional procedures, doctors could only rely on their "intuition" and "hearing" to determine if they had obtained a satisfactory sample. However, the new spectral analysis probes or miniature ultrasound sensors can be directly integrated at the tip of the biopsy needle. They can analyze the optical or acoustic properties of the tissue at the moment of sampling and immediately determine whether the sample contains suspicious cells. If an unqualified sample is detected, the system will immediately prompt the doctor to take additional samples to avoid the embarrassing situation of "performing an unnecessary biopsy". This will increase the initial success rate of the procedure from the current 85%-90% to nearly 100%.

Ethics and Challenges: Technology is Always Just a Tool

Of course, intelligent programs also face challenges: high equipment costs, data privacy protection, and barriers to trust from doctors regarding new technologies. More importantly, no matter how powerful AI is, the final diagnostic decision-making authority and the responsibility for patient communication still need to be borne by doctors. The ideal model for the future is: AI and robots are responsible for "precise execution", while doctors focus on "humanistic care" and "comprehensive judgment".

The breast biopsy procedure is on the verge of becoming intelligent. The significance of this transformation goes far beyond technological advancement; it lies in enabling every woman to receive safer, more accurate, and more personalized medical services when dealing with breast health issues.